Wearing your heart in your sleeve?

beta-blocker treatment in patients with advanced heart failure. Effects on neurohormones. Int J Cardiol 2000; 73: 7–12. [7] Effects of metoprolol CR in patients with ischemic and dilated cardiomyopathy: the randomized evaluation of strategies for left ventricular dysfunction pilot study. Circulation 2000; 101: 378–84. [8] Cice G, Tagliamonte E, Ferrara L, Iacono A. Efficacy of carvedilol on complex ventricular arrhythmias in dilated cardiomyopathy: double-blind, randomized, placebo-controlled study. Eur Heart J 2000; 21: 1259–64. [9] Sanderson JE, Yeung LY, Chan S et al. Effect of betablockade on baroreceptor and autonomic function in heart failure. Clin Sci 1999; 96: 137–46. [10] Merlet P, Benvenuti C, Moyse D et al. Prognostic value of MIBG imaging in idiopathic dilated cardiomyopathy. J Nucl Med 1999; 40: 917–23. [11] Agostini D, Belin A, Amar MH et al. Improvement of cardiac neuronal function after carvedilol treatment in dilated cardiomyopathy: a 123I-MIBG scintigraphic study. J Nucl Med 2000; 41: 845–51. [12] Dickstein K, Manhenke C, Aarsland T, McNay J, Wiltse C, Wright T. The effects of chronic, sustained-release moxonidine therapy on clinical and neurohumoral status in patients with heart failure. Int J Cardiol 2000; 75: 167–76. [13] Swedberg K, Bergh CH, Dickstein K, McNay J, Steinberg M. Moxonidine Investigators. The effects of moxonidine, a novel imidazoline, on plasma norepinephrine in patients with congestive heart failure. J Am Coll Cardiol 2000; 35: 398–404. [14] Tygesen H, Andersson B, Di Lenarda A et al. Potential risk of beta-blockade withdrawal in congestive heart failure due to abrupt autonomic changes. Int J Cardiol 1999; 68: 171–7. [15] Coats AJ. Heart Failure 99 — the MOXCON story. Int J Cardiol 1999; 71: 109–11.